Le Lézard
Classified in: Health, Science and technology
Subject: FDA

Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.'s Brovana® (Arformoterol Tartrate Inhalation Solution 15 mcg/ 2mL)


MUMBAI, India, June 23, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL from the United States Food and Drug Administration (US FDA).

Cipla Logo

Cipla's Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.'s Brovana®.

Brovana® is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for:

According to IQVIA (IMS Health), Brovana® had US sales of approximately $438M for the 12-month period ending April 2021.

The product is available for shipping immediately.

About Cipla:

Established in 1935, Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets. Our strengths in the respiratory, anti-retroviral, urology, cardiology, anti-infective and CNS segments are well-known. Our 46 manufacturing sites around the world produce 50+ dosage forms and 1,500+ products using cutting-edge technology platforms to cater to our 80+ markets. Cipla is ranked 3rd largest in pharma in India (IQVIA MAT April' 21), 3rd largest in the pharma private market in South Africa (IQVIA MAT April'21), and is among the most dispensed generic players in the U.S. For over eight decades, making a difference to patients has inspired every aspect of Cipla's work. Our paradigm- changing offer of a triple anti-retroviral therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 is widely acknowledged as having contributed to bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. A responsible corporate citizen, Cipla's humanitarian approach to healthcare in pursuit of its purpose of 'Caring for Life' and deep-rooted community links wherever it is present make it a partner of choice to global health bodies, peers and all stakeholders. For more, please visit www.cipla.com, or click on Twitter, Facebook, LinkedIn.

For queries, please contact:

Corporate Communications
Heena Kanal
E-Mail: CorpComm@cipla.com  

Investor Relations
Naveen Bansal
E-Mail: Investor.Relations@cipla.com

SOURCE Cipla


These press releases may also interest you

at 11:25
Information Services Group (ISG) , a leading global technology research and advisory firm, has launched a research study examining service providers supporting enterprise adoption and management of Salesforce solutions. The study results will be...

at 11:21
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "MOCVD Equipment for Power Electronics - Global Market Trajectory & Analytics". The report presents fresh...

at 11:20
MediStreams, a leading provider of remittance, reconciliation, and payment automation revenue cycle management solutions for healthcare providers, is pleased to announce that TT Capital Partners ("TTCP"), a leading healthcare private equity investor,...

at 11:20
Calix, Inc. today announced that CCI Systems has won the 2021 Calix Partner of the Year award. Announced at Calix ConneXions 2021 in Las Vegas, this award recognizes a partner for their overall business performance, level of innovation, and positive...

at 11:20
Dallas-based Traxo, Inc., the global leader in real-time corporate travel data capture and pre-trip auditing, and International SOS, the world's largest provider of health and security services, announced today a new commercial agreement, which can...

at 11:20
Today, AstraZeneca, in continued partnership with Bob Harper ? host of The Biggest Loser, best-selling author and heart attack survivor ? announced the unveiling of the Survivors Have Heart Second Chance Portraits, a series of photographs that...



News published on 23 june 2021 at 07:00 and distributed by: